Conning Inc’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Sell
753
-179
-19% -$90.1K 0.01% 239
2025
Q4
$435K Sell
932
-237
-20% -$110K 0.01% 235
2025
Q3
$498K Hold
1,169
0.02% 232
2025
Q2
$448K Sell
1,169
-62
-5% -$22.3K 0.02% 245
2025
Q1
$425K Sell
1,231
-38
-3% -$12.2K 0.01% 252
2024
Q4
$381K Sell
1,269
-105
-8% -$36.7K 0.01% 262
2024
Q3
$558K Sell
1,374
-17
-1% -$6.22K 0.02% 225
2024
Q2
$447K Buy
1,391
+21
+2% +$6.82K 0.02% 233
2024
Q1
$457K Sell
1,370
-55
-4% -$16.8K 0.02% 235
2023
Q4
$386K Sell
1,425
-10
-0.7% -$2.47K 0.01% 247
2023
Q3
$353K Buy
1,435
+50
+4% +$13.7K 0.01% 245
2023
Q2
$420K Sell
1,385
-225
-14% -$62.6K 0.01% 240
2023
Q1
$425K Sell
1,610
-123
-7% -$31.2K 0.01% 248
2022
Q4
$416K Sell
1,733
-301
-15% -$67.4K 0.01% 258
2022
Q3
$374K Sell
2,034
-287
-12% -$57.2K 0.01% 257
2022
Q2
$390K Sell
2,321
-26
-1% -$5.59K 0.01% 274
2022
Q1
$588K Sell
2,347
-20
-0.8% -$5.02K 0.02% 236
2021
Q4
$608K Sell
2,367
-78
-3% -$19.1K 0.02% 226
2021
Q3
$593K Sell
2,445
-645
-21% -$158K 0.02% 242
2021
Q2
$639K Sell
3,090
-312
-9% -$63.6K 0.02% 240
2021
Q1
$641K Sell
3,402
-340
-9% -$60K 0.02% 237
2020
Q4
$615K Buy
3,742
+10
+0.3% +$1.46K 0.02% 248
2020
Q3
$465K Buy
3,732
+50
+1% +$6.19K 0.02% 278
2020
Q2
$357K Sell
3,682
-217
-6% -$22.6K 0.01% 313
2020
Q1
$350K Sell
3,899
-121
-3% -$15.7K 0.01% 290
2019
Q4
$594K Buy
4,020
+60
+2% +$8.06K 0.02% 279
2019
Q3
$477K Buy
3,960
+20
+0.5% +$2.58K 0.02% 322
2019
Q2
$533K Sell
3,940
-770
-16% -$97.4K 0.02% 303
2019
Q1
$614K Buy
4,710
+220
+5% +$29.5K 0.02% 309
2018
Q4
$559K Sell
4,490
-780
-15% -$105K 0.02% 314
2018
Q3
$733K Sell
5,270
-420
-7% -$52.3K 0.02% 314
2018
Q2
$584K Sell
5,690
-50
-0.9% -$5.06K 0.02% 361
2018
Q1
$557K Buy
5,740
+120
+2% +$11.6K 0.02% 373
2017
Q4
$494K Sell
5,620
-680
-11% -$54.6K 0.02% 417
2017
Q3
$501K Hold
6,300
0.02% 401
2017
Q2
$549K Sell
6,300
-30
-0.5% -$2.54K 0.02% 383
2017
Q1
$563K Sell
6,330
-230
-4% -$19.2K 0.02% 373
2016
Q4
$486K Sell
6,560
-570
-8% -$42.7K 0.02% 392
2016
Q3
$539K Buy
7,130
+30
+0.4% +$2.3K 0.02% 376
2016
Q2
$547K Buy
7,100
+30
+0.4% +$2.37K 0.02% 358
2016
Q1
$552K Buy
7,070
+590
+9% +$41.2K 0.02% 339
2015
Q4
$438K Buy
6,480
+1,980
+44% +$138K 0.02% 390
2015
Q3
$348K Buy
4,500
+340
+8% +$30.1K 0.02% 420
2015
Q2
$377K Buy
4,160
+1,000
+32% +$80.1K 0.02% 446
2015
Q1
$238K Buy
+3,160
New +$227K 0.01% 536

Other funds holding HCA

Conning Inc's HCA Position: Q1 2026 in Review

Conning Inc reduced its HCA Healthcare (HCA) stake by 19% in Q1 2026, selling an estimated $90.1K and leaving 753 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #239.

Conning Inc first reported a position in HCA in Q1 2015 and has held it in 45 quarters since. The position peaked at $733K in Q3 2018. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Conning Inc held 753 shares of HCA Healthcare worth $356K as of Q1 2026.
  • Conning Inc sold 179 HCA Healthcare shares in Q1 2026, an estimated $90.1K.
  • HCA Healthcare made up 0.01% of Conning Inc's portfolio in Q1 2026, its #239 holding.
  • Conning Inc first reported a position in HCA Healthcare in Q1 2015 and has held it in 45 quarters since.
  • Conning Inc's HCA Healthcare position peaked at $733K in Q3 2018.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.